Brief: Enlivex Announces Allowance Of New Chinese Patent Covering Allocetra Immunotherapy
16/09/2020 13:33
Sept 16 (Reuters) - Enlivex Therapeutics Ltd ENLV.TA :
* ENLIVEX ANNOUNCES ALLOWANCE OF NEW CHINESE PATENT COVERING
ALLOCETRA IMMUNOTHERAPY
* ENLIVEX THERAPEUTICS LTD - EXPECTS THAT THIS NEW PATENT
WILL BE
ISSUED IN CHINA DURING Q4 OF 2020
Source text for Eikon: ID:nGNX12Mchb
Further company coverage: ENLV.TA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enlivex
See all newsBrief: Enlivex Ltd Registers Up To 23,333,333 Ordinary Shares For Resale By Selling Shareholder
Brief: Enlivex Announces Second Regulatory Approval For Phase 2B Trial Of Allocetra In Age-Related Primary Moderate-To-Severe Knee Osteoarthritis
Brief: Enlivex Therapeutics Files For Offering Of Up To $299.6 Mln Of Ordinary Shares
Brief: Enlivex Announces Positive 6-Month Topline Data For Patients with Knee Osteoarthritis
Brief: Enlivex Files Patent for Allocetra Use in Osteoarthritis Treatment